Extracellular vesicles compartment in liquid biopsies: Clinical application.
暂无分享,去创建一个
Gorjana Rackov | Á. Ayuso-Sacido | G. Rackov | Noemi Garcia-Romero | Susana Esteban-Rubio | Josefa Carrión-Navarro | Cristobal Belda-Iniesta | Angel Ayuso-Sacido | C. Belda-Iniesta | N. García-Romero | J. Carrión-Navarro | S. Esteban-Rubio
[1] J. Parsons,et al. Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.
[2] E. Salazar,et al. Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients. , 2013, Archives of medical research.
[3] Yangchao Chen,et al. Novel therapeutic targets for pancreatic cancer. , 2014, World journal of gastroenterology.
[4] P. Simioni,et al. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women , 2015, Scandinavian journal of clinical and laboratory investigation.
[5] P. Simioni,et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. , 2011, Thrombosis research.
[6] Anil Vachani,et al. Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA , 2016, Clinical Cancer Research.
[7] A. Lièvre,et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Beiyi Shen,et al. Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors* , 2011, The Journal of Biological Chemistry.
[9] Mary Bebawy,et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells , 2013, RNA biology.
[10] G. Raskob,et al. Global Burden of Thrombosis: Epidemiologic Aspects. , 2016, Circulation research.
[11] B. Carter,et al. Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients , 2014, Expert review of molecular diagnostics.
[12] M. Peeters,et al. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials. , 2015, European journal of cancer.
[13] K. Dobos,et al. Exosomes: New Tuberculosis Biomarkers – Prospects From the Bench to the Clinic , 2012 .
[14] Hakho Lee,et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.
[15] H. Kubo,et al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility , 2012, Thorax.
[16] M. A. van de Laar,et al. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[17] Richard W. Farndale,et al. Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.
[18] T. Wurdinger,et al. Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer , 2015, Oncotarget.
[19] Jian-Bing Fan,et al. miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles , 2012, Molecular therapy. Nucleic acids.
[20] I. Perrotta,et al. Exosomes in human atherosclerosis: An ultrastructural analysis study , 2016, Ultrastructural pathology.
[21] G. Nickenig,et al. Circulating CD 31 1 / Annexin V 1 microparticles correlate with cardiovascular outcomes , 2011 .
[22] Clotilde Théry,et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.
[23] A. Vickers,et al. Tumor markers in prostate cancer I: Blood-based markers , 2011, Acta oncologica.
[24] Peter A Keyel,et al. Coordinate Stimulation of Macrophages by Microparticles and TLR Ligands Induces Foam Cell Formation , 2012, The Journal of Immunology.
[25] A. Ranjan,et al. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas. , 2017, Journal of neurosurgery.
[26] Ming-Lin Liu,et al. Microparticles: new light shed on the understanding of venous thromboembolism , 2014, Acta Pharmacologica Sinica.
[27] Robin P Boushey,et al. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. , 2009, Clinics in colon and rectal surgery.
[28] A. Tedgui,et al. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. , 2006, Hypertension.
[29] R. Scienza,et al. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role , 2013, Thrombosis and Haemostasis.
[30] J. Redón,et al. Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus , 2015, PloS one.
[31] Lorenzo Silengo,et al. Extracellular vesicles as an emerging mechanism of cell-to-cell communication , 2012, Endocrine.
[32] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[33] Cynthia A. Schandl,et al. Major DNA Fragmentation Is a Late Event in Apoptosis , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] F. Sánchez‐Madrid,et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.
[35] D. Grootendorst,et al. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. , 2014, Clinical colorectal cancer.
[36] Lei Wang,et al. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer , 2017, Journal of cellular and molecular medicine.
[37] K. Kodys,et al. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis , 2015, Journal of Translational Medicine.
[38] X. Breakefield,et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer , 2009, British Journal of Cancer.
[39] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[40] M. Johnson,et al. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study , 2015, PloS one.
[41] M. Mayr,et al. Novel methodologies for biomarker discovery in atherosclerosis. , 2015, European heart journal.
[42] Y. Castier,et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.
[43] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[44] G. Andriole,et al. The Case for Prostate Cancer Screening with Prostate-Specific Antigen , 2006 .
[45] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[46] D. Pisetsky,et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] Yusuke Yoshioka,et al. Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis , 2013, The Journal of Biological Chemistry.
[48] C. Rudin,et al. Small cell lung cancer: Where do we go from here? , 2015, Cancer.
[49] 三宅 智博. GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer , 2013 .
[50] S. Hanash,et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] H. Ogawa,et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. , 2009, Journal of the American College of Cardiology.
[52] G. Holtrop,et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status , 2014, Journal of Thrombosis and Thrombolysis.
[53] M. Iacocca,et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] E. McDermott,et al. Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer , 2004, British Journal of Cancer.
[55] Michele Guescini,et al. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA , 2009, Journal of Neural Transmission.
[56] Qinghua Lu,et al. Correlation between serum exosome derived miR-208a and acute coronary syndrome. , 2015, International journal of clinical and experimental medicine.
[57] In‐San Kim,et al. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer , 2016 .
[58] A. Orekhov,et al. Increased Shedding of Microvesicles from Intimal Smooth Muscle Cells in Athero-Prone Areas of the Human Aorta: Implications for Understanding of the Predisease Stage , 2012, Pathobiology.
[59] S. Pomeroy,et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.
[60] Chantal M Boulanger,et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.
[61] M A Firpo,et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. , 2013, Current molecular medicine.
[62] C. Hack,et al. Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.
[63] Y. Okada,et al. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas , 2000, International journal of cancer.
[64] D. Neuberg,et al. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study) , 2013, British journal of haematology.
[65] G. Nickenig,et al. MicroRNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease , 2014, Journal of the American Heart Association.
[66] B. Howard,et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[67] E. Assenat,et al. KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma , 2016, Clinical and Translational Gastroenterology.
[68] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[69] D. Tang,et al. Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer , 2013, PloS one.
[70] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[71] J. Pérez-Gracia,et al. Circulating melanoma exosomes as diagnostic and prognosis biomarkers. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[72] X. Shu,et al. Genetic polymorphisms in glutathione‐S‐transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma , 2005, Cancer.
[73] A. O’Connor,et al. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types , 2012, BMC Genomics.
[74] Tamara Wurst. Liquid Biopsies. , 2018, Genetic testing and molecular biomarkers.
[75] Dan Mercola,et al. Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer , 2012, PloS one.
[76] F. Ghiringhelli,et al. Precision medicine in breast cancer: reality or utopia? , 2017, Journal of Translational Medicine.
[77] Tina Koestler,et al. Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients , 2015 .
[78] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[79] J. Ordi‐Ros,et al. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[80] J. Hansen,et al. Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study , 2014, Journal of the American Heart Association.
[81] B. Ylstra,et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. , 2014, Cell reports.
[82] D. Corella,et al. CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. , 2016, International journal of cardiology.
[83] Y. Yoshioka,et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. , 2013, Die Pharmazie.
[84] C. Johnsen,et al. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[85] P. Simioni,et al. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia. , 2015, Thrombosis research.
[86] Salma Khan,et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer , 2014, BMC Cancer.
[87] Tomohiro Sakamoto,et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.
[88] H. Lim,et al. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[89] H. Kato,et al. Plasma proteomics of lung cancer by a linkage of multi‐dimensional liquid chromatography and two‐dimensional difference gel electrophoresis , 2006, Proteomics.
[90] M. Record,et al. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. , 2007, Biochimie.
[91] T. Visakorpi,et al. Different gDNA Content in the Subpopulations of Prostate Cancer Extracellular Vesicles: Apoptotic Bodies, Microvesicles, and Exosomes , 2014, The Prostate.
[92] R. Bertina,et al. Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.
[93] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[94] Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction , 2016 .
[95] R. González-Amaro,et al. Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease , 2015, Clinical and experimental immunology.
[96] R. Bertina,et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. , 2010, Thrombosis research.
[97] G. Angelini,et al. Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery , 2016, PloS one.
[98] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[99] Xiao-Ming Yin,et al. Mitophagy: mechanisms, pathophysiological roles, and analysis , 2012, Biological chemistry.
[100] Derek H. Oakley,et al. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. , 2016, Neuro-oncology.
[101] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[102] C. Scharf,et al. Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN , 2014, Journal of molecular cell biology.
[103] Ian N Bruce,et al. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus , 2013, Annals of the rheumatic diseases.
[104] Romaric Lacroix,et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. , 2013, Journal of the American College of Cardiology.
[105] W. Ding,et al. Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.
[106] L. Horstman,et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.
[107] Yuan Zhang,et al. Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC , 2011, Electrophoresis.
[108] John T. Wei,et al. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. , 2016, JAMA oncology.
[109] In‐San Kim,et al. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection , 2015, Clinical Cancer Research.
[110] Mef Nilbert,et al. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis , 2014, Acta oncologica.
[111] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[112] Si-ying Zhou,et al. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer. , 2017, Gene.
[113] L. Theodorsen,et al. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE). , 1979, Scandinavian journal of clinical and laboratory investigation.
[114] Yong-mei Li,et al. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population , 2017, Oncology letters.
[115] F. Breedveld,et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.
[116] L. Strotman,et al. Liquid Biopsies in Oncology and the Current Regulatory Landscape , 2016, Molecular Diagnosis & Therapy.
[117] N. Vitale,et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2 , 2014, Nature Communications.
[118] P. Altevogt,et al. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation , 2012, PLoS biology.
[119] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[120] Olivier Elemento,et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection , 2014, Cell Research.
[121] Hakho Lee,et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy , 2012, Nature Medicine.
[122] L. Horstman,et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. , 2005, Journal of the American College of Cardiology.
[123] Amaia Agirre,et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. , 2014, Neuro-oncology.
[124] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[125] M. Alonso,et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients , 2016, Oncotarget.
[126] Franck Molina,et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA , 2014, Nature Medicine.
[127] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[128] P. Quesenberry,et al. Role of Alix in miRNA packaging during extracellular vesicle biogenesis , 2016, International journal of molecular medicine.